Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 49% ± 14% | |
lung | 19 studies | 42% ± 17% | |
intestine | 11 studies | 30% ± 11% | |
brain | 11 studies | 29% ± 9% | |
kidney | 7 studies | 35% ± 11% | |
bone marrow | 5 studies | 38% ± 14% | |
lymph node | 5 studies | 45% ± 9% | |
liver | 5 studies | 41% ± 17% | |
pancreas | 4 studies | 54% ± 21% | |
eye | 4 studies | 20% ± 5% | |
uterus | 4 studies | 53% ± 15% | |
breast | 4 studies | 32% ± 6% | |
placenta | 3 studies | 71% ± 11% | |
heart | 3 studies | 23% ± 9% | |
adipose | 3 studies | 27% ± 10% | |
adrenal gland | 3 studies | 30% ± 9% | |
skin | 3 studies | 29% ± 12% | |
prostate | 3 studies | 25% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6988.72 | 1445 / 1445 | 100% | 55.35 | 183 / 183 |
liver | 100% | 3379.75 | 226 / 226 | 100% | 45.95 | 406 / 406 |
lung | 100% | 11389.84 | 578 / 578 | 100% | 69.40 | 1155 / 1155 |
ovary | 100% | 4086.82 | 180 / 180 | 100% | 68.74 | 430 / 430 |
uterus | 100% | 8609.31 | 170 / 170 | 100% | 82.36 | 459 / 459 |
thymus | 100% | 6198.31 | 653 / 653 | 100% | 47.46 | 604 / 605 |
intestine | 100% | 7190.13 | 966 / 966 | 100% | 62.95 | 526 / 527 |
bladder | 100% | 6137.76 | 21 / 21 | 100% | 67.02 | 503 / 504 |
breast | 100% | 7101.50 | 459 / 459 | 100% | 68.45 | 1113 / 1118 |
stomach | 99% | 4320.94 | 357 / 359 | 100% | 58.32 | 286 / 286 |
prostate | 100% | 5687.21 | 244 / 245 | 99% | 35.33 | 497 / 502 |
brain | 98% | 3842.45 | 2600 / 2642 | 100% | 43.93 | 705 / 705 |
kidney | 100% | 5000.26 | 89 / 89 | 98% | 44.01 | 886 / 901 |
skin | 100% | 8439.06 | 1807 / 1809 | 98% | 62.19 | 464 / 472 |
adrenal gland | 100% | 5352.90 | 258 / 258 | 96% | 30.74 | 220 / 230 |
pancreas | 92% | 2675.54 | 303 / 328 | 99% | 68.83 | 177 / 178 |
adipose | 100% | 8121.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 130.14 | 29 / 29 |
spleen | 100% | 12107.42 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 67.50 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 50.91 | 1 / 1 |
blood vessel | 100% | 8249.96 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 21820.76 | 927 / 929 | 0% | 0 | 0 / 0 |
heart | 94% | 2947.13 | 810 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 17.61 | 63 / 80 |
muscle | 15% | 254.04 | 119 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030833 | Biological process | regulation of actin filament polymerization |
GO_0034314 | Biological process | Arp2/3 complex-mediated actin nucleation |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0016477 | Biological process | cell migration |
GO_0005885 | Cellular component | Arp2/3 protein complex |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0005925 | Cellular component | focal adhesion |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_1904813 | Cellular component | ficolin-1-rich granule lumen |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0030027 | Cellular component | lamellipodium |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0005200 | Molecular function | structural constituent of cytoskeleton |
GO_0051015 | Molecular function | actin filament binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ARPC5 |
Protein name | ARPC5 protein Actin-related protein 2/3 complex subunit 5 Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit) (p16-ARC) |
Synonyms | ARC16 |
Description | FUNCTION: Component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) . The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility . In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA . The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) . . FUNCTION: Functions as component of the Arp2/3 complex which is involved in regulation of actin polymerization and together with an activating nucleation-promoting factor (NPF) mediates the formation of branched actin networks. Arp2/3 complex plays a critical role in the control of cell morphogenesis via the modulation of cell polarity development. . |
Accessions | B1ALC0 ENST00000367534.5 Q6IPM3 ENST00000294742.6 [O15511-2] O15511 ENST00000359856.11 [O15511-1] |